Greenway Medical Technologies Announces Pricing of its Initial Public Offerings
Greenway Medical Technologies, Inc. (“Greenway®”) (NYSE: GWAY), provider of the integrated, single-database electronic health record (EHR), practice management and interoperability solution PrimeSUITE® 2011, today announced the pricing of its initial public offering of 6,666,667 shares of common stock at $10.00 per share. Greenway is offering 5,388,833 shares of common stock and selling stockholders are offering 1,277,834 shares of common stock. In addition, the underwriters were granted a 30-day option to purchase up to 1,000,000 additional shares of common stock from Greenway at the initial public offering price. Greenway will not receive any proceeds from the sale of shares by the selling stockholders. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol "GWAY" on February 2, 2012.
J.P. Morgan and Morgan Stanley are acting as active book-runners and William Blair is acting as passive book-runner. The offering is being made solely by means of a prospectus forming part of the effective registration statement, copies of which may be obtained, when available, from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by calling toll-free at 1-866-803-9204; from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 (Tel: 1-866-718-1649), Email: email@example.com; William Blair & Company, Attn: Prospectus Department, 222 West Adams Street, Chicago, IL 60606: 1-800-621-0687.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on February 1, 2012. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Pamlico Capital is a private equity firm founded in 1988 that invests in growing middle market companies in North America. Pamlico Capital seeks control-oriented growth equity investments of up to $200 million alongside founders and proven leaders in its target industries: business & technology services, communications, and healthcare. Since inception, the firm, based in Charlotte, NC, has invested approximately $4 billion. For additional information, please visit www.pamlicocapital.com.